Membership
Tour
Register
Log in
Medicinal preparations containing organic active ingredients
Follow
Industry
CPC
A61K31/00
This industry / category may be too specific. Please go to a parent level for more data
Parent Industries
A
HUMAN NECESSITIES
A61
Medical science
A61K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Current Industry
A61K31/00
Medicinal preparations containing organic active ingredients
Sub Industries
A61K31/01
Hydrocarbons
A61K31/015
carbocyclic
A61K31/02
Halogenated hydrocarbons
A61K31/025
carbocyclic
A61K31/03
aromatic
A61K31/035
having aliphatic unsaturation
A61K31/04
Nitro compounds
A61K31/045
Hydroxy compounds
A61K31/047
having two or more hydroxy groups
A61K31/05
Phenols
A61K31/055
the aromatic ring being substituted by halogen
A61K31/06
the aromatic ring being substituted by nitro groups
A61K31/065
Diphenyl-substituted acyclic alcohols
A61K31/07
Retinol compounds
A61K31/075
Ethers or acetals
A61K31/08
acyclic
A61K31/085
having an ether linkage to aromatic ring nuclear carbon
A61K31/09
having two or more such linkages
A61K31/095
Sulfur, selenium, or tellurium compounds
A61K31/10
Sulfides Sulfoxides Sulfones
A61K31/105
Persulfides
A61K31/11
Aldehydes
A61K31/115
Formaldehyde
A61K31/12
Ketones
A61K31/121
acyclic
A61K31/122
having the oxygen directly attached to a ring
A61K31/125
Camphor Nuclear substituted derivatives thereof
A61K31/13
Amines
A61K31/131
acylic
A61K31/132
having two or more amino groups
A61K31/133
having hydroxy groups
A61K31/135
having aromatic rings
A61K31/136
having the amino group directly attached to the aromatic ring
A61K31/137
Arylalkylamines
A61K31/138
Aryloxyalkylamines
A61K31/14
Quaternary ammonium compounds
A61K31/145
having sulfur
A61K31/15
Oximes (>C=N-O-) Hydrazines (>N-N<) Hydrazones (>N-N=) Imines (C-N=C)
A61K31/155
Amidines ()
A61K31/16
Amides
A61K31/164
of a carboxlic acid with an aminoalcohol
A61K31/165
having aromatic rings
A61K31/166
having the carbon of a carboxamide group directly attached to the aromatic ring
A61K31/167
having the nitrogen of a carboxamide group directly attached to the aromatic ring
A61K31/17
having the group >N-C(O)-N< or >N-C(S)-N<
A61K31/175
having the group , >N-C(O)-N=N- or
A61K31/18
Sulfonamides
A61K31/185
Acids Anhydrides, halides or salts thereof
A61K31/19
Carboxylic acids
A61K31/191
having two or more hydroxy groups
A61K31/192
having aromatic groups
A61K31/194
having two or more carboxyl groups
A61K31/195
having an amino group
A61K31/196
the amino group being directly attached to a ring
A61K31/197
the amino and the carboxyl group being attached to the same acyclic carbon chain
A61K31/198
Alpha-aminoacids
A61K31/20
having a carboxyl group bound to a chain of seven or more carbon atoms
A61K31/201
having one or two double bonds
A61K31/202
having three or more double bonds
A61K31/203
Retinoic acids Salts thereof
A61K31/205
Amine addition salts of organic acids Inner quaternary ammonium salts
A61K31/21
Esters
A61K31/215
of carboxylic acids
A61K31/216
of acids having aromatic rings
A61K31/22
of acyclic acids
A61K31/221
with compounds having an amino group
A61K31/222
with compounds having aromatic groups
A61K31/223
of alpha-aminoacids
A61K31/225
Polycarboxylic acids
A61K31/23
of acids having a carboxyl group bound to a chain of seven or more carbon atoms
A61K31/231
having one or two double bonds
A61K31/232
having three or more double bonds
A61K31/235
having an aromatic ring attached to a carboxyl group
A61K31/24
having an amino or nitro group
A61K31/245
Amino benzoic acid types
A61K31/25
with polyoxyalkylated alcohols
A61K31/255
of sulfoxy acids or sulfur analogues thereof
A61K31/26
Cyanate or isoyanate esters Thiocyanate or isothiocyanate esters
A61K31/265
of carbonic, thiocarbonic, or thiocarboxylic acids
A61K31/27
of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
A61K31/275
Nitriles Isonitriles
A61K31/277
having a ring
A61K31/28
Compounds containing heavy metals
A61K31/282
Platinum compounds
A61K31/285
Arsenic compounds
A61K31/29
Antimony or bismuth compounds
A61K31/295
Iron group metal compounds
A61K31/30
Copper compounds
A61K31/305
Mercury compounds
A61K31/31
containing nitrogen
A61K31/315
Zinc compounds
A61K31/32
Tin compounds
A61K31/325
Carbamic acids Thiocarbamic acids Anhydrides or salts thereof
A61K31/327
Peroxy compounds
A61K31/33
Heterocyclic compounds
A61K31/335
having oxygen as the only ring hetero atom
A61K31/336
having three-membered rings
A61K31/337
having four-membered rings
A61K31/34
having five-membered rings with one oxygen as the only ring hetero atom
A61K31/341
not condensed with another ring
A61K31/343
condensed with a carbocyclic ring
A61K31/345
Nitrofurans
A61K31/35
having six-membered rings with one oxygen as the only ring hetero atom
A61K31/351
not condensed with another ring
A61K31/352
condensed with carbocyclic rings
A61K31/353
3,4-Dihydrobenzopyrans
A61K31/355
Tocopherols
A61K31/357
having two or more oxygen atoms in the same ring
A61K31/36
Compounds containing methylenedioxyphenyl groups
A61K31/365
Lactones
A61K31/366
having six-membered rings
A61K31/37
Coumarins
A61K31/375
Ascorbic acid
A61K31/38
having sulfur as a ring hetero atom
A61K31/381
having five-membered rings
A61K31/382
having six-membered rings
A61K31/385
having two or more sulfur atoms in the same ring
A61K31/39
having oxygen in the same ring
A61K31/395
having nitrogen as a ring hetero atom
A61K31/396
having thre-membered rings
A61K31/397
having four-membered rings
A61K31/40
having five-membered rings with one nitrogen as the only ring hetero atom
A61K31/401
Proline Derivatives thereof
A61K31/4015
having oxo groups directly attached to the heterocyclic ring
A61K31/402
1-aryl substituted
A61K31/4025
not condensed and containing further heterocyclic rings
A61K31/403
condensed with carbocyclic rings
A61K31/4035
Isoindoles
A61K31/404
Indoles
A61K31/4045
Indole-alkylamines Amides thereof
A61K31/405
Indole-alkanecarboxylic acids Derivatives thereof
A61K31/407
condensed with other heterocyclic ring systems
A61K31/409
having four such rings
A61K31/41
having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen
A61K31/415
1,2-Diazoles
A61K31/4152
having oxo groups directly attached to the heterocyclic ring
A61K31/4155
non condensed and containing further heterocyclic rings
A61K31/416
condensed with carbocyclic ring systems
A61K31/4162
condensed with heterocyclic ring systems
A61K31/4164
1,3-Diazoles
A61K31/4166
having oxo groups directly attached to the heterocyclic ring
A61K31/4168
having a nitrogen attached in position 2
A61K31/417
Imidazole-alkylamines
A61K31/4172
Imidazole-alkanecarboxylic acids
A61K31/4174
Arylalkylimidazoles
A61K31/4178
not condensed 1,3-diazoles and containing further heterocyclic rings
A61K31/4184
condensed with carbocyclic rings
A61K31/4188
condensed with other heterocyclic ring systems
A61K31/4192
1,2,3-Triazoles
A61K31/4196
1,2,4-Triazoles
A61K31/42
Oxazoles
A61K31/421
1,3-Oxazoles
A61K31/422
not condensed and containing further heterocyclic rings
A61K31/423
condensed with carbocyclic rings
A61K31/424
condensed with heterocyclic ring systems
A61K31/4245
Oxadiazoles
A61K31/425
Thiazoles
A61K31/426
1,3-Thiazoles
A61K31/427
not condensed and containing further heterocyclic rings
A61K31/428
condensed with carbocyclic rings
A61K31/429
condensed with heterocyclic ring systems
A61K31/43
Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula
A61K31/431
containing further heterocyclic rings
A61K31/433
Thidiazoles
A61K31/435
having six-membered rings with one nitrogen as the only ring hetero atom
A61K31/4353
ortho- or peri-condensed with heterocyclic ring systems
A61K31/4355
the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
A61K31/436
the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e..g. rapamycin
A61K31/4365
the heterocyclic ring system having sulfur as a ring hetero atom
A61K31/437
the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom
A61K31/4375
the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom
A61K31/438
the ring being spiro-condensed with carbocyclic ring systems
A61K31/439
the ring forming part of a bridged ring system
A61K31/44
Non condensed pyridines Hydrogenated derivatives thereof
A61K31/4402
only substituted in position 2
A61K31/4406
only substituted in position 3
A61K31/4409
only substituted in position 4
A61K31/4412
having oxo groups directly attached to the heterocyclic ring
A61K31/4415
Pyridoxine
A61K31/4418
having a carbocyclic group directly attached to the heterocyclic ring
A61K31/4422
1,4-Dihydropyridines
A61K31/4425
Pyridinium derivatives
A61K31/4427
containing further heterocyclic ring systems
A61K31/443
containing a five-membered ring with oxygen as a ring hetero atom
A61K31/4433
containing a six-membered ring with oxygen as a ring hetero atom
A61K31/4436
containing a heterocyclic ring having sulfur as a ring hetero atom
A61K31/4439
containing a five-membered ring with nitrogen as a ring hetero atom
A61K31/444
containing a six-membered ring with nitrogen as a ring heteroatom
A61K31/445
Non condensed piperidines
A61K31/4453
only substituted in position 1
A61K31/4458
only substituted in position 2
A61K31/4462
only substituted in position 3
A61K31/4465
only substituted in position 4
A61K31/4468
having a nitrogen directly attached in position 4
A61K31/45
having oxo groups directly attached to the heterocyclic ring
A61K31/451
having a carbocyclic group directly attached to the heterocyclic ring
A61K31/4515
having a butyrophenone group in position 1
A61K31/452
Piperidinium derivatives
A61K31/4523
containing further heterocyclic ring systems
A61K31/4525
containing a five-membered ring with oxygen as a ring hetero atom
A61K31/453
containing a six-membered ring with oxygen as a ring hetero atom
A61K31/4535
containing a heterocyclic ring having sulfur as a ring hetero atom
A61K31/454
containing a five-membered ring with nitrogen as a ring hetero atom
A61K31/4545
containing a six-membered ring with nitrogen as a ring hetero atom
A61K31/455
Nicotinic acids
A61K31/46
8-Azabicyclo [3.2.1] octane Derivatives thereof
A61K31/465
Nicotine Derivatives thereof
A61K31/47
Quinolines Isoquinolines
A61K31/4704
2-Quinolinones
A61K31/4706
4-Aminoquinolines 8-Aminoquinolines
A61K31/4709
Non-condensed quinolines and containing further heterocyclic rings
A61K31/472
Non-condensed isoquinolines
A61K31/4725
containing further heterocyclic rings
A61K31/473
ortho- or peri-condensed with carbocyclic ring systems
A61K31/4738
ortho- or peri-condensed with heterocyclic ring systems
A61K31/4741
condensed with ring systems having oxygen as a ring hetero atom
A61K31/4743
condensed with ring systems having sulfur as a ring hetero atom
A61K31/4745
condensed with ring systems having nitrogen as a ring hetero atom
A61K31/4747
Spiro-condensed
A61K31/4748
forming part of bridged ring systems
A61K31/475
having an indole ring
A61K31/48
Ergoline derivatives
A61K31/485
Morphinan derivatives
A61K31/49
Cinchonan derivatives
A61K31/495
having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms
A61K31/496
Non-condensed piperazines containing further heterocyclic rings
A61K31/4965
Non-condensed pyrazines
A61K31/497
containing further heterocyclic rings
A61K31/498
Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems
A61K31/4985
Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
A61K31/499
Spiro-condensed pyrazines or piperazines
A61K31/4995
Pyrazines or piperazines forming part of bridged ring systems
A61K31/50
Pyridazines Hydrogenated pyridazines
A61K31/501
not condensed and containing further heterocyclic rings
A61K31/502
ortho- or peri-condensed with carbocyclic ring systems
A61K31/5025
ortho- or peri-condensed with heterocyclic ring systems
A61K31/503
spiro-condensed
A61K31/504
forming part of bridged ring systems
A61K31/505
Pyrimidines Hydrogenated pyrimidines
A61K31/506
not condensed and containing further heterocyclic rings
A61K31/51
Thiamines
A61K31/513
having oxo groups directly attached to the heterocyclic ring
A61K31/515
Barbituric acids Derivatives thereof
A61K31/517
ortho- or peri-condensed with carbocyclic ring systems
A61K31/519
ortho- or peri-condensed with heterocyclic rings
A61K31/52
Purines
A61K31/522
having oxo groups directly attached to the heterocyclic ring
A61K31/525
Isoalloxazines
A61K31/527
spiro-condensed
A61K31/529
forming part of bridged ring systems
A61K31/53
having six-membered rings with three nitrogens as the only ring hetero atoms
A61K31/535
having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms
A61K31/5355
non-condensed oxazines and containing further heterocyclic rings
A61K31/536
ortho- or peri-condensed with carbocyclic ring systems
A61K31/5365
ortho- or peri-condensed with heterocyclic ring systems
A61K31/537
spiro-condensed or forming part of bridged ring systems
A61K31/5375
1,4-Oxazines
A61K31/5377
not condensed and containing further heterocyclic rings
A61K31/538
ortho- or peri-condensed with carbocyclic ring systems
A61K31/5383
ortho- or peri-condensed with heterocyclic ring systems
A61K31/5386
Spiro-condensed or forming part of bridged ring systems
A61K31/539
having two or more oxygen atoms in the same ring
A61K31/5395
having two or more nitrogen atoms in the same ring
A61K31/54
having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms
A61K31/541
non-condensed thiazines containing further heterocyclic rings
A61K31/5415
ortho- or peri-condensed with carbocyclic ring systems
A61K31/542
ortho- or peri-condensed with heterocyclic ring systems
A61K31/545
Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:
A61K31/546
containing further heterocyclic rings
A61K31/547
spiro-condensed or forming part of bridged ring systems
A61K31/548
having two or more sulfur atoms in the same ring
A61K31/549
having two or more nitrogen atoms in the same ring
A61K31/55
having seven-membered rings
A61K31/551
having two nitrogen atoms
A61K31/5513
1,4-Benzodiazepines
A61K31/5517
condensed with five-membered rings having nitrogen as a ring hetero atom
A61K31/553
having at least one nitrogen and one oxygen as ring hetero atoms
A61K31/554
having at least one nitrogen and one sulfur as ring hetero atoms
A61K31/555
containing heavy metals
A61K31/557
Eicosanoids
A61K31/5575
having a cyclopentane
A61K31/5578
having a pentalene ring system
A61K31/558
having heterocyclic rings containing oxygen as the only ring hetero atom
A61K31/5585
having five-membered rings containing oxygen as the only ring hetero atom
A61K31/559
having heterocyclic rings containing hetero atoms other than oxygen
A61K31/56
Compounds containing cyclopenta[a]hydrophenanthrene ring systems Derivatives
A61K31/565
not substituted in position 17 beta by a carbon atom
A61K31/566
having an oxo group in position 17
A61K31/567
substituted in position 17 alpha
A61K31/568
substituted in positions 10 and 13 by a chain having at least one carbon atom
A61K31/5685
having an oxo group in position 17
A61K31/569
substituted in position 17 alpha
A61K31/57
substituted in position 17 beta by a chain of two carbon atoms
A61K31/573
substituted in position 21
A61K31/575
substituted in position 17 beta by a chain of three or more carbon atoms
A61K31/58
containing heterocyclic rings
A61K31/585
containing lactone rings
A61K31/59
Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
A61K31/592
9,10-Secoergostane derivatives, e.g. ergocalciferol
A61K31/593
9,10-Secocholestane derivatives, e.g. cholecalciferol
A61K31/60
Salicylic acid Derivatives thereof
A61K31/603
having further aromatic rings
A61K31/606
having amino groups
A61K31/609
Amides
A61K31/612
having the hydroxy group in position 2 esterified
A61K31/616
by carboxylic acids
A61K31/618
having the carboxyl group in position 1 esterified
A61K31/621
having the hydroxy group in position 2 esterified
A61K31/625
having heterocyclic substituents
A61K31/63
Compounds containing para-N-benzenesulfonyl-N-groups
A61K31/635
having a heterocyclic ring
A61K31/64
Sulfonylureas
A61K31/65
Tetracyclines
A61K31/655
Azo (-N=N-), diazo (=N2), azoxy (>N-O-N< or N(=O)-N<), azido (-N3) or diazoamino (-N=N-N<) compounds
A61K31/66
Phosphorus compounds
A61K31/661
Phosphorus acids or esters thereof not having P-C bonds
A61K31/6615
Compounds having two or more esterified phosphorus acid groups
A61K31/662
Phosphorus acids or esters thereof having P-C bonds
A61K31/663
Compounds having two or more phosphorus acid groups or esters thereof
A61K31/664
Amides of phosphorus acids
A61K31/665
having oxygen as a ring hetero atom
A61K31/67
having sulfur as a ring hetero atom
A61K31/675
having nitrogen as a ring hetero atom
A61K31/683
Diesters of a phosphorus acid with two hydroxy compounds
A61K31/685
one of the hydroxy compounds having nitrogen atoms
A61K31/688
both hydroxy compounds having nitrogen atoms
A61K31/69
Boron compounds
A61K31/695
Silicon compounds
A61K31/70
Carbohydrates Sugars Derivatives thereof
A61K31/7004
Monosaccharide having only carbon, hydrogen and oxygen atoms
A61K31/7008
Compounds having an amino group directly attached to a carbon atom of the saccharide radical
A61K31/7012
Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical
A61K31/7016
Disaccharides
A61K31/702
Oligosaccharides
A61K31/7024
Esters of saccharides
A61K31/7028
Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
A61K31/7032
attached to a polyol, i.e. compound having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage
A61K31/7034
attached to a carbocyclic compound
A61K31/7036
having at least one amino group directly attached to the carbocyclic ring
A61K31/704
attached to a condensed carbocyclic ring system
A61K31/7042
Compounds having saccharide radicals and heterocyclic rings
A61K31/7048
having oxygen as a ring hetero atom
A61K31/7052
having nitrogen as a ring hetero atom
A61K31/7056
containing five-membered rings with nitrogen as a ring hetero atom
A61K31/706
containing six-membered rings with nitrogen as a ring hetero atom
A61K31/7064
containing condensed or non-condensed pyrimidines
A61K31/7068
having oxo groups directly attached to the pyrimidine ring
A61K31/7072
having two oxo groups directly attached to the pyrimidine ring
A61K31/7076
containing purines
A61K31/708
having oxo groups directly attached to the purine ring system
A61K31/7084
Compounds having two nucleosides or nucleotides
A61K31/7088
Compounds having three or more nucleosides or nucleotides
A61K31/7105
Natural ribonucleic acids
A61K31/711
Natural deoxyribonucleic acids
A61K31/7115
Nucleic acids or oligonucleotides having modified bases
A61K31/712
Nucleic acids or oligonucleotides having modified sugars
A61K31/7125
Nucleic acids or oligonucleotides having modified internucleoside linkage
A61K31/713
Double-stranded nucleic acids or oligonucleotides
A61K31/7135
Compounds containing heavy metals
A61K31/714
Cobalamins, e.g. cyanocobalamin
A61K31/715
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages Derivatives thereof
A61K31/716
Glucans
A61K31/717
Celluloses
A61K31/718
Starch or degraded starch
A61K31/719
Pullulans
A61K31/721
Dextrans
A61K31/722
Chitin, chitosan
A61K31/723
Xanthans
A61K31/724
Cyclodextrins
A61K31/726
Glycosaminoglycans
A61K31/727
Heparin Heparan
A61K31/728
Hyaluronic acid
A61K31/729
Agar Agarose Agaropectin
A61K31/731
Carrageenans
A61K31/732
Pectin
A61K31/733
Fructosans
A61K31/734
Alginic acid
A61K31/736
Glucomannans or galactomannans
A61K31/737
Sulfated polysaccharides
A61K31/738
Cross-linked polysaccharides
A61K31/739
Lipopolysaccharides
A61K31/74
Synthetic polymeric materials
A61K31/745
Polymers of hydrocarbons
A61K31/75
of ethene
A61K31/755
Polymers containing halogen
A61K31/76
of vinyl chloride
A61K31/765
Polymers containing oxygen
A61K31/77
of oxiranes
A61K31/775
Phenolic resins
A61K31/78
of acrylic acid or derivatives thereof
A61K31/785
Polymers containing nitrogen
A61K31/787
containing heterocyclic rings having nitrogen as a ring hetero atom
A61K31/79
Polymers of vinyl pyrrolidone
A61K31/795
Polymers containing sulfur
A61K31/80
Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
Industries
Overview
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
Compositions comprising levan and use thereof
Patent number
11,964,041
Issue date
Apr 23, 2024
GAN SHMUEL FOODS LTD.
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Topical composition for the control of pain in animals
Patent number
11,964,046
Issue date
Apr 23, 2024
ALBERTA VETERINARY LABORATORIES LTD
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Cannabis wrapper for smoking articles
Patent number
11,963,547
Issue date
Apr 23, 2024
Mativ Holdings, Inc.
A24 - TOBACCO CIGARS CIGARETTES SMOKERS' REQUISITES
Information
Patent Grant
Mixtures of cannabinoid compounds, and production and use thereof
Patent number
11,964,955
Issue date
Apr 23, 2024
Symrise AG
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
Patent number
11,964,961
Issue date
Apr 23, 2024
Pfizer Inc.
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Oral taxane compositions and methods
Patent number
11,963,942
Issue date
Apr 23, 2024
Health Hope Pharma Ltd
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Method for treating obesity, diabetes, cardiovascular and kidney di...
Patent number
11,963,949
Issue date
Apr 23, 2024
UNM Rainforest Innovations
G01 - MEASURING TESTING
Information
Patent Grant
Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypy...
Patent number
11,963,950
Issue date
Apr 23, 2024
Loxo Oncology Inc.
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Pharmaceutical compositions
Patent number
11,963,951
Issue date
Apr 23, 2024
XSPRAY PHARMA AB
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Deuterated compounds for restoring mutant p53 function
Patent number
11,963,953
Issue date
Apr 23, 2024
PMV PHARMACEUTICALS, INC.
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Methods and compositions of inhibiting DCN1-UBC12 interaction
Patent number
11,963,954
Issue date
Apr 23, 2024
Memorial Sloan Kettering Cancer Center
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)
Patent number
11,963,956
Issue date
Apr 23, 2024
Forma Therapeutics, Inc.
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Small molecules for mouse satellite cell proliferation
Patent number
11,963,964
Issue date
Apr 23, 2024
President and Fellows of Harvard College
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Methods of treating cystic fibrosis transmembrane conductance regul...
Patent number
11,963,965
Issue date
Apr 23, 2024
National Jewish Health
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Deoxy-cytidine or uridine derivatives for use in cancer therapies
Patent number
11,963,973
Issue date
Apr 23, 2024
HEMISPHERIAN AS
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Fused heterocyclic compounds as RET kinase inhibitors
Patent number
11,964,988
Issue date
Apr 23, 2024
Array Biopharma Inc.
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
MicroRNA and inhibitors thereof and methods of treatment
Patent number
11,965,162
Issue date
Apr 23, 2024
The Johns Hopkins University
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Grant
Amphiphilic polynucleotides
Patent number
11,965,164
Issue date
Apr 23, 2024
Duke University
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Grant
Method of manufacturing stable emulsions and compositions containin...
Patent number
11,963,936
Issue date
Apr 23, 2024
University of Florida Research Foundation, Inc.
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Use of cannabinoids in the treatment of epilepsy
Patent number
11,963,937
Issue date
Apr 23, 2024
GW Research Limited
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Use of a fasting mimicking diet to enhance the efficacy of antiestr...
Patent number
11,963,941
Issue date
Apr 23, 2024
UNIVERSITA' DEGLI STUDI DI
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
2-(4-chlorophenyl)-4,5-bis(4-chlorophenyl)-1H-imidazole as an antim...
Patent number
11,963,948
Issue date
Apr 23, 2024
KING FAISAL UNIVERSITY
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Anti-androgens for the treatment of metastatic castration-sensitive...
Patent number
11,963,952
Issue date
Apr 23, 2024
Aragon Pharmaceuticals, Inc.
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Treating cardiovascular disease by selectively eliminating senescen...
Patent number
11,963,957
Issue date
Apr 23, 2024
Mayo Foundation for Medical Education and Research
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Grant
Compounds for treating or inhibiting recurrence of acute myeloid le...
Patent number
11,963,960
Issue date
Apr 23, 2024
Flash Therapeutics, LLC
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Phospholipid compounds and uses thereof
Patent number
11,963,967
Issue date
Apr 23, 2024
Gilead Sciences, Inc.
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Treatment of hearing loss
Patent number
11,963,968
Issue date
Apr 23, 2024
Massachusetts Eye and Ear Infirmary
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Method for prevention or treatment of amyotrophic lateral sclerosis...
Patent number
11,963,969
Issue date
Apr 23, 2024
Buddhist Tzu Chi Medical Foundation
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Heparin composition for treating ischemia
Patent number
11,963,976
Issue date
Apr 23, 2024
National Cheng Kung University
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
HNF4a saRNA compositions and methods of use
Patent number
11,965,163
Issue date
Apr 23, 2024
Mina Therapeutics Limited
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Patents Applications
last 30 patents
Information
Patent Application
METHODS OF TREATMENT
Publication number
20240122886
Publication date
Apr 18, 2024
Arena Pharmaceuticals, Inc.
John W. ADAMS
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
DRY POWDER COMPOSITIONS OF TREPROSTINIL PRODRUGS AND METHODS OF USE...
Publication number
20240122889
Publication date
Apr 18, 2024
Insmed Incorporated
Gerald O’Brien
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
PHEROMONE DIFFUSING GEL
Publication number
20240122892
Publication date
Apr 18, 2024
VIRBAC
Aurélie Girardin
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
LASOFOXIFENE COMBINATION TREATMENT OF ER+ BREAST CANCER THAT HAS PR...
Publication number
20240122896
Publication date
Apr 18, 2024
Sermonix Pharmaceuticals, Inc.
David J. PORTMAN
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
DMT SALTS AND THEIR USE TO TREAT BRAIN INJURY
Publication number
20240122897
Publication date
Apr 18, 2024
ALGERNON PHARMACEUTICALS INC.
Mark WILLIAMS
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
METHOD OF MODULATING TIGIT AND PD-1 SIGNALLING PATHWAYS USING 1,2,4...
Publication number
20240122904
Publication date
Apr 18, 2024
AURIGENE DISCOVERY TECHNOLOGIES LIMITED
Pottayil Govindan Nair SASIKUMAR
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
PHARMACEUTICAL COMPOSITION
Publication number
20240122905
Publication date
Apr 18, 2024
MedinCell S.A.
Maria Dimitrova Ferrand
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
METHODS OF TREATING MELANOMA WITH RIPRETINIB
Publication number
20240122906
Publication date
Apr 18, 2024
Deciphera Pharmaceuticals, LLC
Ying Su
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
SOLID FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AM...
Publication number
20240122910
Publication date
Apr 18, 2024
Akebia Therapeutics, Inc.
James Densmore Copp
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
KETAMINE OR DEXTROMETHORPHAN FORMULATIONS AND METHODS OF USE
Publication number
20240122919
Publication date
Apr 18, 2024
West Virginia University
Scott Pollard
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Methods Of Treating Cancer With Transmembrane Protein 16F (TMEM16F)...
Publication number
20240122922
Publication date
Apr 18, 2024
Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cance...
Igor Astsaturov
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
METHODS OF TREATING HIDRADENITIS SUPPURATIVA
Publication number
20240122923
Publication date
Apr 18, 2024
ABBVIE INC.
Aileen L. PANGAN
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
APELIN RECEPTOR MODULATORS FOR TREATING MUSCLE CONDITIONS
Publication number
20240122926
Publication date
Apr 18, 2024
BioAge Labs, Inc.
Kristen Patricia FORTNEY
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
INTEGRIN INHIBITORS AND USES THEREOF IN COMBINATION WITH OTHER AGENTS
Publication number
20240122930
Publication date
Apr 18, 2024
Pliant Therapeutics, Inc.
Eric LEFEBVRE
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
MATERNAL VITAMIN B2 ADMINISTRATION FOR THE PREVENTION OF INCREASED...
Publication number
20240122935
Publication date
Apr 18, 2024
SOCIETE DES PRODUITS NESTLE S.A.
Cyrus Cooper
A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information
Patent Application
METHODS AND COMPOSITIONS FOR REDUCING BODY FAT AND ADIPOCYTES
Publication number
20240122942
Publication date
Apr 18, 2024
Topokine Therapeutics, Inc.
Murat V. Kalayoglu
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
USE OF NEUROACTIVE STEROIDS FOR TREATMENT OF SEXUAL DYSFUNCTION
Publication number
20240122945
Publication date
Apr 18, 2024
SAGE THERAPEUTICS, INC.
Vijayveer BONTHAPALLY
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Application of Naringin Combined with Rapamycin in Preparation of M...
Publication number
20240122956
Publication date
Apr 18, 2024
AIR FORCE MEDICAL UNIVERSITY
Lina Niu
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
USE OF NICOTINAMIDE MONONUCLEOTIDE (NMN) FOR THE PREVENTION AND/OR...
Publication number
20240122957
Publication date
Apr 18, 2024
NUVAMID SA
Guillaume BERMOND
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
COMPOSITION AND METHOD FOR REDUCING OXALATE LEVELS IN PATIENTS RECE...
Publication number
20240122960
Publication date
Apr 18, 2024
CHARITE-UNIVERSITATSMEDIZIN BERLIN
Felix KNAUF
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
ENHANCED NITRATE COMPOSITIONS AND METHODS OF USE
Publication number
20240122966
Publication date
Apr 18, 2024
ThermoLife International, LLC
Alexandros Nikolaidis
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
COMPOSITIONS AND METHODS FOR CARDIOMYOCYTE TRANSPLANTATION
Publication number
20240122990
Publication date
Apr 18, 2024
University of Washington
Charles E. MURRY
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
WITHANOLIDE-ENRICHED COMPOSITIONS AND METHODS OF USE THEREOF
Publication number
20240123016
Publication date
Apr 18, 2024
Franco Cavaleri
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
MINIMALLY TOXIC PRODRUGS
Publication number
20240123074
Publication date
Apr 18, 2024
COBIORES NV
André TROUET
B82 - NANO-TECHNOLOGY
Information
Patent Application
HYDROGEL PRODRUG FOR TREATMENT
Publication number
20240123082
Publication date
Apr 18, 2024
Viking Scientific, Inc.
Paul Fisher
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
PHARMACEUTICAL FORMULATIONS OF INDOLEAMINE 2, 3-DIOXYGENASE INHIBITORS
Publication number
20240122857
Publication date
Apr 18, 2024
Bristol-Myers Squibb Company
Jing TAO
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
NEW PHARMACEUTICAL COMPOSITIONS
Publication number
20240122863
Publication date
Apr 18, 2024
CALLIDITAS THERAPEUTICS AB
Eva Kristina RIESEL
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
COMPOSITIONS AND METHODS FOR TREATMENT OF MICROBIAL INFECTIONS
Publication number
20240122872
Publication date
Apr 18, 2024
Epitop, Inc.
Byung Eui KIM
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
COMPOSITIONS COMPRISING EXOPOLYSACCHARIDES AND USES THEREOF
Publication number
20240124617
Publication date
Apr 18, 2024
DANSTAR FERMENT A.G.
Frédéric DURMONT
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Application
ABRASION-RESISTANT FREE-FLOWING GLYCOCYAMINE-CONTAINING MOLDINGS AN...
Publication number
20240122211
Publication date
Apr 18, 2024
ALZCHEM TROSTBERG GMBH
Stephan WINKLER
A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES